NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues
NRXSNeuraxis(NRXS) GlobeNewswire News Room·2024-11-12 21:10

CARMEL, Ind., Nov. 12, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the third quarter period ended September 30, 2024. 3Q24 Financial Highlights Revenues increased 40% to $667 thousand in the three months ended September 30, 2024 (the “3Q24”) compared to $477 thousand in the three months ended Septe ...